DNMT1 is an independent risk factor, highly expressed in HCC tissues and positively associated with many tumor microenvironments (TME) infiltrating immune cells, promoting the malignant progression of HCC and strongly associated with poor prognosis in HCC patients (Gu et al., 2021). This evidence concerns the gene DNMT1 and hepatocellular carcinoma.